Drug Profile
Allotrap 07
Alternative Names: B7.75-84Latest Information Update: 07 Feb 2001
Price :
$50
*
At a glance
- Originator SangStat
- Developer INSERM; SangStat
- Class Peptides
- Mechanism of Action Cytotoxic T lymphocyte inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Transplant rejection in France (Unknown route)
- 07 Feb 2001 Discontinued-Preclinical for Transplant rejection in USA (Unknown route)
- 09 Jan 1995 Preclinical development for Transplant rejection in France (Unknown route)